Population
human Kv1.5 (hKv1.5) delayed rectifier channels expressed in human embryonic kidney cells
Comparison
Quinidine (10 to 100 microM) vs Control (no quinidine)
Design
Preclinical
Authors
Loading...
Supports Kv1.5-targeted drug design; leaves open clinical translation from animal models to human arrhythmias.
Quinidine blocks human Kv1.5 channels by binding to a site that becomes accessible only upon channel opening, without affecting kinetic states prior to opening.
David Fedida (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: